Naoyuki Kamatani Selected Research

Rheumatoid Arthritis

10/2008	Granzyme B Induces Apoptosis of Chondrocytes with Natural Killer Cell-like Cytotoxicity in Rheumatoid Arthritis.
09/2008	Molecular aspects of rheumatoid arthritis: role of transcription factors.
04/2008	Prospective study of the association between NAT2 gene haplotypes and severe adverse events with sulfasalazine therapy in patients with rheumatoid arthritis.
01/2008	Clinical and radiological features of pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study.
12/2007	Detection of six single-nucleotide polymorphisms associated with rheumatoid arthritis by a loop-mediated isothermal amplification method and an electrochemical DNA chip.
12/2007	Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis.
09/2007	Anti-arthritis effects of vitamin K(2) (menaquinone-4)--a new potential therapeutic strategy for rheumatoid arthritis.
02/2007	[Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis]
01/2007	Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observational cohort (IORRA).
01/2007	Genetic association between the PRKCH gene encoding protein kinase Ceta isozyme and rheumatoid arthritis in the Japanese population.
01/2007	Risk factors for total knee arthroplasty in rheumatoid arthritis.
01/2006	One third of Japanese patients with rheumatoid arthritis use complementary and alternative medicine.
01/2006	Acceptability and usefulness of mizoribine in the management of rheumatoid arthritis in methotrexate-refractory patients and elderly patients, based on analysis of data from a large-scale observational cohort study.
01/2006	Hypersensitivity reaction against influenza vaccine in a patient with rheumatoid arthritis after the initiation of etanercept injections.
01/2006	Efficacy profile of bucillamine in rheumatoid arthritis patients in a large observational cohort study, IORRA.
09/2005	[Association of polymorphisms in genes of osteoclastogenesis-related cytokines with severity in patients with rheumatoid arthritis]
01/2005	Asymptomatic interstitial pneumonitis induced by bucillamine in a patient with rheumatoid arthritis.
10/2004	Rituximab for rheumatoid arthritis.
08/2004	Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
07/2004	Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
01/2004	Cartilage oligomeric matrix protein in serum and synovial fluid of rheumatoid arthritis: potential use as a marker for joint cartilage damage.
01/2004	Myelodysplastic syndrome associated with low-dose methotrexate in rheumatoid arthritis.
06/2003	Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis.
12/2002	Adverse effects of sulfasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene.
04/2002	Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses.
02/2002	[Possible roles of TNF family cytokines in bone destruction of rheumatoid arthritis]

Articles by Research Topic

Disease

26	Rheumatoid Arthritis 10/2008 - 02/2002
7	Systemic Scleroderma (Systemic Sclerosis) 09/2006 - 09/2002
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2008 - 06/2004
4	Neoplasms (Cancer) 08/2008 - 06/2004
3	Syndrome 01/2008 - 02/2003
2	Gouty Arthritis 06/2004 - 09/2002
2	Dermatomyositis (Dermatopolymyositis) 06/2004 - 08/2002
1	Osteoarthritis 05/2008
1	Anaphylaxis (Anaphylactic Shock) 04/2008
1	Gout 03/2008
1	Panniculitis 01/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2008
1	Pneumonia (Pneumonitis) 01/2008
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2008
1	Fasciitis (Fascitis) 01/2008
1	Confusion (Bewilderment) 10/2007
1	Delirium 10/2007
1	Arthritis (Polyarthritis) 09/2007
1	Obesity 03/2007
1	Experimental Arthritis 01/2007
1	Hypertrophic Cardiomyopathy (Asymmetric Septal Hypertrophy) 01/2007
1	Pancreatitis 01/2006
1	Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis) 01/2006
1	Hypersensitivity (Allergy) 01/2006
1	Myocardial Infarction 01/2006
1	Cryptorchidism (Undescended Testes) 08/2005
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2005
1	Central Nervous System Lupus Vasculitis 11/2004
1	Urolithiasis 10/2004
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 06/2004
1	Fibrosis (Cirrhosis) 01/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2004
1	Hemorrhage 10/2003
1	Pulmonary Hypertension (Ayerza Syndrome) 02/2003
1	Sclerosing Cholangitis 01/2003
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 10/2002

Drug/Important Bio-Agent (IBA)

5	Methotrexate (Mexate)FDA LinkGeneric 01/2008 - 04/2002
3	Uric Acid (Urate)IBA 03/2008 - 09/2002
3	CytokinesIBA 09/2005 - 02/2002
2	irinotecan (Camptosar)FDA LinkGeneric 08/2008 - 06/2004
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 04/2008 - 12/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2008 - 02/2002
2	DNA (Deoxyribonucleic Acid)IBA 12/2007 - 01/2006
2	Interleukin-17 (Interleukin 27)IBA 12/2007 - 01/2007
2	Carbon MonoxideIBA 01/2006 - 06/2003
2	bucillamine (SA 96)IBA 01/2006 - 01/2005
1	Granzymes (Granzyme)IBA 10/2008
1	Transcription Factors (Transcription Factor)IBA 09/2008
1	B-Cell Activating FactorIBA 08/2008
1	5' Untranslated Regions (5' UTR)IBA 05/2008
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 04/2008
1	Platelet Activating FactorIBA 04/2008
1	Prednisolone (Predate)FDA LinkGeneric 01/2008
1	HLA-DRB1 antigen (HLA DRB1)IBA 12/2007
1	Interleukin-6 (Interleukin 6)IBA 10/2007
1	Immunoglobulin G (IgG)IBA 10/2007
1	Interleukin-8 (Interleukin 8)IBA 10/2007
1	Interferon-alpha (Interferon Alfa)FDA Link 10/2007
1	Vitamin K 2 (Vitamin K2)IBA 09/2007
1	NeuropeptidesIBA 03/2007
1	secretogranin IIIIBA 03/2007
1	Antirheumatic Agents (DMARD)IBA 02/2007
1	gemcitabine FDA Link 01/2007
1	Interleukin-23 (Interleukin 23)IBA 01/2007
1	Protein Kinases (Protein Kinase)IBA 01/2007
1	Cytidine DeaminaseIBA 01/2007
1	junctophilinIBA 01/2007
1	Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)FDA LinkGeneric 01/2007
1	Proteins (Proteins, Gene)IBA 09/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2006
1	bredinin (mizoribine)IBA 01/2006
1	Interleukin-18 (Interleukin 18)IBA 01/2006
1	Influenza Vaccines (FluMist)IBA 01/2006
1	TNFR-Fc fusion protein (etanercept)FDA Link 01/2006
1	Interferon-gamma (Interferon, gamma)IBA 01/2006
1	RNA (Ribonucleic Acid)IBA 01/2006
1	Estrogen Receptor alphaIBA 08/2005
1	Endocrine DisruptorsIBA 08/2005
1	Chemokine CXCL10IBA 11/2004
1	rituximab (Mabthera)FDA Link 10/2004
1	2,8-dihydroxyadenineIBA 10/2004
1	Adenine PhosphoribosyltransferaseIBA 10/2004
1	Matrix MetalloproteinasesIBA 08/2004
1	Mitogen-Activated Protein KinasesIBA 07/2004
1	BilirubinIBA 06/2004
1	AntibodiesIBA 06/2004
1	Vasopressins (Vasopressin)IBA 06/2004
1	cartilage matrix proteinIBA 01/2004
1	Angiotensin IIIBA 01/2004
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2003
1	Peroxidase (Myeloperoxidase)IBA 10/2003
1	Methylprednisolone FDA LinkGeneric 02/2003
1	BezafibrateIBA 01/2003
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 01/2003
1	Etoposide (VP 16)FDA LinkGeneric 10/2002

Therapy/Procedure

1	Arthroplasty 01/2007
1	Complementary Therapies (Alternative Medicine) 01/2006
1	Plasmapheresis 01/2006
1	Ligation 07/2004